Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice

dc.contributor.authorF Norflus
dc.contributor.authorA Nanje
dc.contributor.authorC-A Gutekunst
dc.contributor.authorG Shi
dc.contributor.authorJ Cohen
dc.date.accessioned2024-05-21T13:41:55Z
dc.date.available2024-05-21T13:41:55Z
dc.identifier.urihttps://hdl.handle.net/20.500.12951/1329
dc.titleAnti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice
dc.typeJournal Article, Academic Journal
dcterms.bibliographicCitationNeurobiology of Disease 17(2), 319-325, (2004)
Files
Collections